Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 363.70
+6.85 (1.92%)
Sep 5, 2025, 3:29 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 485.33 billion as of September 5, 2025. Its market cap has increased by 16.95% in one year.
Market Cap
485.33B
Enterprise Value
683.98B
Revenue
157.71B
Ranking
n/a
PE Ratio
113.37
Stock Price
363.70
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 485.33B, an increase of 968.71%. That is a compound annual growth rate of 11.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 485.33B | 11.00% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | 551.59B | 58.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,796.47B |
| Divi's Laboratories | 1,628.25B |
| Cipla | 1,274.47B |
| Apollo Hospitals Enterprise | 1,135.90B |
| Mankind Pharma | 1,060.34B |
| Zydus Lifesciences | 1,018.26B |
| Fortis Healthcare | 717.06B |
| Alkem Laboratories | 633.87B |